Delivery Order SPE2DB20D1109-SPE2DB22FQ13D
Award Date 9/21/22
Potential Completion Date 10/13/22
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product. The contract, valued at $1,380.52, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). The contract has an ultimate completion date of August 14, 2024, and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen is a well-established federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $4,590.10 firm fixed price delivery order is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, in support of military treatment programs and facilities. The award is not set aside and is part of a larger indefinite delivery...
- This federal contract award is for the delivery of the pharmaceutical product RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML to the Defense Logistics Agency (DLA). The $2,775.00 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $1,195.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has an ultimate completion date of June 25, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to various federal agencies,...
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,526.30 firm-fixed-price contract is for the provision of 300 mcg/2 mL RHOPHYLAC syringes. There is no set-aside designation for this award. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain capabilities to fulfill federal government contracts, particularly with...
- This federal contract award is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, to the U.S. Department of Defense (DoD) and its Medical Supply Chain agency. The contract, valued at $4,590.10, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 12, 2024. The contract has a completion date of July 5, 2024 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. Amerisourcebergen holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, with a firm-fixed price of $1,387.50 and a ceiling value of $1,387.50. The delivery order does not have a set-aside designation and is expected to be completed by August 13,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,836.04 firm fixed price contract is for the supply of RHOPHYLAC, a 300 mcg/2 mL syringe medication, with an ultimate completion date of October 15, 2024. The award does not utilize a set-aside designation. AmerisourceBergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, collectively valued up to...
- This contract award to AmerisourceBergen Drug Corp. Corporate Office Division provides for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, to support the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $2,302.03, is a firm-fixed price delivery order that does not utilize any set-aside designation. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. The contract has a firm fixed price of $1,377.03 and an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...